Kenneth Stumpf
Podiatrist · Indianapolis, INNPI 1629208103
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.7%), education and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Trilliant Surgical LLC. at 54.7% of the total. Reporting peaked in 2019 at $2,000 and has fallen 73.6% since, to $528 in 2025.
Across 16 payments — averaging $228.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Trilliant Surgical LLC.$2K
- Osteomed LLC$1K
- Globus Medical$227
- Stryker$191
- Fusion Orthopedics USA, LLC$110
- Johnson & Johnson$91
- plus $39 from 2 others
What the payments were for
- Speaking & faculty fees$2,00055%
- Food & beverage$65818%
- Education$1,00027%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Trilliant Surgical LLC. | 2 | $2,000 |
| Osteomed LLC | 1 | $1,000 |
| Globus Medical | 2 | $227 |
| Stryker | 3 | $191 |
| Fusion Orthopedics USA, LLC | 2 | $110 |
| Johnson & Johnson | 4 | $91 |
| Shockwave Medical, Inc | 1 | $23 |
| Convatec Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXT-Cannulated$1,000
- EXT-Encompass$1,000
- EXT-Extremilock Foot$1,000
- EXT-ExtremiLock Ankle$1,000
- EXT-Staple$1,000
- Tiger Cannulated Screw$1,000
- Arsenal$1,000
- EASYFUSE$148
- Senza$141
How this compares
$3,658 in reported general payments places this provider in the 70th percentile of 131 podiatrist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 30 | $1,407 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 43 | $1,274 |
| Methylprednisolone | 61 | $349 |
| Cephalexin | 40 | $192 |
| Doxycycline Hyclate | 16 | $170 |
| Clindamycin Hcl | 17 | $93 |
| Meloxicam | 26 | $92 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Indianapolis
- Anthony MillerIndianapolis$292K
- Corey GrohIndianapolis$57K
- Jeffrey StevensIndianapolis$56K
- Clinton HeyerIndianapolis$8K
- Lynette MeeceIndianapolis$5K
- Jeremy SpauldingIndianapolis$4K
- Austin QuebedeauxIndianapolis$3K
- Elizabeth MorrisonIndianapolis$2K
- Todd MannIndianapolis$2K
- Craig ShouseIndianapolis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.